drug discovery for membrane targets

target gene to lead compound

Structure 27, 1-12, March 5, 2019

our drug discovery focus: membrane proteins


© Peter Wiegand, PSI

disruptive technologies

medicines with unprecendented specificity and efficacy



leadXpro's CEO co-authors book on structure biology

January 2, 2020
In a recently issued book on structural biology, Michael Hennig co-authored the chapter on biophysical assessment of target protein quality. More about it in the media section.

2019-12-20 News ParkInnovAare Mieter

leadXpro secures space to grow in new innovation campus

November 11, 2019
leadXpro is the first company to sign a tenancy agreement for Park InnovAare's new innovation campus.

This website is using cookies. If you continue to use this site you agree to our privacy policy. Our privacy policy